Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Recently Added News

6/14/2024
BreakingCataractRegulationSurgical
WPS MAC Revisits Changing Coverage for Cataract Surgery
WPS MAC Revisits Changing Coverage for Cataract Surgery

WPS Insurance Corporation, a Medicare administrative contractor (MAC) in the US, has again proposed changing its coverage of cataract surgery after putting forth a similar proposal in September 202...

6/14/2024
BreakingClinical TrialGlaucomaIndustry
Skye Drops Glaucoma Program After Phase IIa Failure, Shifts Focus to Obesity
Skye Drops Glaucoma Program After Phase IIa Failure, Shifts Focus to Obesity

Skye Bioscience reported June 10 that it was discontinuing its ophthalmology program after its synthetic cannabinoid derivative SBI-100, a glaucoma drop candidate, failed to meet its Phase IIa prim...

6/14/2024
BreakingDiagnosticGlaucomaOCTRetina
Nidek Launches RS-1 Glauvas OCT System
Nidek Launches RS-1 Glauvas OCT System

Japan’s Nidek announced June 3 that it had launched the RS-1 Glauvas optical coherence tomography (OCT) system. The device is CE marked as a Class IIa device. Nidek said the RS-1 Glauvas’ streamlin...

6/14/2024
BreakingCornealDry Eye
BioTissue Introduces Shelf-Stable CAM360 AmnioGraft for Dry Eye, Other Disorders
BioTissue Introduces Shelf-Stable CAM360 AmnioGraft for Dry Eye, Other Disorders

BioTissue announced June 3 that it was launching the CAM360 AmnioGraft, a new hydrated, shelf-stable cryopreserved amniotic membrane product for mild to moderate dry eye and other ocular surface di...

6/14/2024
BreakingData SecurityRegulation
ARPA-H Launches UPGRADE to Strengthen Hospitals’ Cybersecurity
ARPA-H Launches UPGRADE to Strengthen Hospitals’ Cybersecurity

ARPA-H announced May 30 a program called UPGRADE, designed to eliminate cyberattacks on hospitals by developing tools that proactively probe digital hospital environments for software weaknesses. A...

6/14/2024
BreakingCataractEuropeIOLRegulationSurgical
Nidek Gains CE Marking for Preloaded IOL Injector System
Nidek Gains CE Marking for Preloaded IOL Injector System

Japan’s Nidek announced June 10 that it had received CE marking for the NP-1/NP-1C preloaded IOL injection system. The system is preloaded with the Aktis aspheric hydrophobic soft acrylic lens, whi...

6/14/2024
BreakingPharmaRegulationRetina
Belite Bio Receives Sakigake (Pioneer Drug) Nod in Japan for Tinlarebant in Stargardt
Belite Bio Receives Sakigake (Pioneer Drug) Nod in Japan for Tinlarebant in Stargardt

Belite Bio announced June 12 that Japanese regulators had granted the Sakigake, or pioneer therapy, designation to its lead candidate, tinlarebant, an oral tablet targeting Stargardt disease. Belit...

6/14/2024
BreakingDeviceFundingProsthesisRetina
LambdaVision Reports First Closing of Seed Round to Advance Artificial Retina
LambdaVision Reports First Closing of Seed Round to Advance Artificial Retina

LambdaVision, of Farmington, Connecticut, reported May 29 that it had secured the first closing of a seed round, let by Aurelia Foundry Fund, a fund spun out of Massachusetts Institute of Technolog...

6/14/2024
BreakingGene TherapyIndustryRetina
Regenxbio Appoints Simpson as President, CEO; Co-founder Mills Transitions to Chairman
Regenxbio Appoints Simpson as President, CEO; Co-founder Mills Transitions to Chairman

Regenxbio announced June 12 that its chief operating officer, Curran Simpson, had been appointed president and chief executive officer. He will also join the board of directors. Co-founder Kenneth ...

6/7/2024
BreakingGlaucomaRegulationSurgical
MACs Propose New Limits on MIGS Procedures
MACs Propose New Limits on MIGS Procedures

Five Medicare administrative contractors have proposed new limits to their coverage of minimally invasive glaucoma surgery (MIGS). The move comes a year after the same MACs roiled the glaucoma subs...

6/7/2024
BreakingDry Eye
Nordic Pharma Launches Lacrifill Canalicular Gel for Dry Eye in US
Nordic Pharma Launches Lacrifill Canalicular Gel for Dry Eye in US

Nordic Pharma announced May 29 that it had launched Lacrifill canalicular gel for dry eye in the US. Lacrifill is a cross-linked hyaluronic acid derivative intended to temporarily block tear draina...

6/7/2024
BreakingClinical TrialGene TherapyRegulationRetina
US FDA Gives Green Light to Trial of Avirmax’ Gene Therapy Candidate for Wet AMD with PCV
US FDA Gives Green Light to Trial of Avirmax’ Gene Therapy Candidate for Wet AMD with PCV

Avirmax Biopharma announced May 30 that the US FDA had cleared its investigational new drug application for a Phase I/IIa clinical trial of its intravitreal gene therapy candidate targeting wet age...

Past News Stories

6/7/2024
BreakingCornealEuropeRegulation
Acanthamoeba Keratitis Eye Drop Candidate from SIFI Gains Positive CHMP Opinion
Acanthamoeba Keratitis Eye Drop Candidate from SIFI Gains Positive CHMP Opinion

Italy’s SIFI announced May 31 that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency recommended approval of Akantior (polihexanide 0.08%) for the treatment...

6/7/2024
DealsRefractiveSurgical
Sightpath Medical Acquires LASIK Services Business PennVista
Sightpath Medical Acquires LASIK Services Business PennVista

Sightpath Medical announced May 30 that it had acquired PennVista, a LASIK services business operating in Pennsylvania, Ohio, West Virginia, Indiana, and Michigan. Financial details were not disclo...

6/7/2024
BreakingDiagnostic
Quantel Medical Launches Pocket III Hand-held Pachymeter
Quantel Medical Launches Pocket III Hand-held Pachymeter

Quantel Medical, a division of France's Lumibird Medical, announced May 30 the launch of the Pocket III hand-held pachymeter to measure the thickness of the cornea. Quantel says the Pocket III ...

5/31/2024
BreakingDealsPharmaRetina
Merck to Acquire Retinal Drug Developer EyeBio in Deal Worth up to $3 Billion
Merck to Acquire Retinal Drug Developer EyeBio in Deal Worth up to $3 Billion

Merck, of Rahway, New Jersey, announced May 29 that it was acquiring Eyebiotech Limited (EyeBio) for an upfront payment of $1.3 billion and up to $1.7 billion in future milestone payments. The deal...

5/31/2024
BreakingCataractIOLOcular CancerRevenueSurgical
Q1-2024 Ophthalmic Revenue Roundup for Amgen, Hoya, and Immunocore
Q1-2024 Ophthalmic Revenue Roundup for Amgen, Hoya, and Immunocore

Amgen, of Thousand Oaks, California, reported May 2 that its Q1-2024 revenue from Tepezza was $424 million. The total consisted of $419 million in the US and $5 million outside the US. The company ...

5/31/2024
BreakingEuropePharmaRegulationRetina
EU Regulators Approve Outlook’s Lytenava (Bevacizumab) for Wet AMD
EU Regulators Approve Outlook’s Lytenava (Bevacizumab) for Wet AMD

Outlook Therapeutics announced May 28 that the European Commission had granted marketing authorization for Lytenava, an ophthalmic formulation of bevacizumab for the treatment of wet age-related ma...

5/31/2024
BreakingCataractIOLRegulationSurgical
Bausch + Lomb Receives Health Canada Approval for EnVista Envy Trifocal IOL
Bausch + Lomb Receives Health Canada Approval for EnVista Envy Trifocal IOL

Bausch + Lomb announced May 28 that Health Canada had approved the enVista Envy trifocal intraocular lens (IOL). It’s the first approval for the new lens. The Envy is expected to be available in Ca...

5/31/2024
BreakingDealsRetina
HanAll Licenses Turn Bio mRNA Technology for Eye and Ear Diseases
HanAll Licenses Turn Bio mRNA Technology for Eye and Ear Diseases

South Korea-based HanAll Biopharma announced May 28 that it had licensed Turn Biotechnologies’ epigenetic reprogramming technology for eye and ear diseases. The company said the deal could be worth...

5/31/2024
BreakingDry EyeRegulation
Santen Recalls All Unexpired Lots of Diquas LX Over Issues with Preservative
Santen Recalls All Unexpired Lots of Diquas LX Over Issues with Preservative

Santen has issued a voluntary recall and suspended shipment for all unexpired lots of its dry eye treatment Diquas LX in Japan due to issues with a preservative, Pharma Japan reported May 23. Sante...

5/31/2024
BreakingClinical TrialEuropeMyopia
Dopavision Sees Positive Results in Trial of Photobiomodulation for Myopia
Dopavision Sees Positive Results in Trial of Photobiomodulation for Myopia

Germany’s Dopavision reported May 28 that its MyopiaX photobiomodulation system targeting myopia showed signals of clinical effect on the rate of progression at six months in a proof-of-concept tri...

5/31/2024
BreakingEuropeMyopiaRegulation
EU Accepts Vyluma’s Marketing Application for Low-Dose Atropine in Childhood Myopia
EU Accepts Vyluma’s Marketing Application for Low-Dose Atropine in Childhood Myopia

Vyluma reported May 29 that the European Medicines Agency had accepted its marketing application for lead compound NVK002, a low-dose formulation of atropine targeting childhood myopia. NVK002 is a...

5/24/2024
BiosimilarsBreakingRegulationRetina
US FDA Approves First Interchangeable Biosimilars to Eylea
US FDA Approves First Interchangeable Biosimilars to Eylea

The FDA announced May 20 that it had approved the US’ first interchangeable biosimilars to Eylea (aflibercept)— Yesafili, from India’s Biocon Biologics, and Opuviz, which was jointly developed by B...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more